Scholarlink

Background <p>Cachexia index (CXI) is a recently proposed biomarker reflecting the cachectic condition, including inflammation, sarcopenia and nutritional status, of patients with various malignancies. We evaluated its prognostic impact in patients undergoing esophagectomy for esophageal cancer (EC).</p> Methods <p>A total of 378 patients were retrospectively reviewed. CXI was calculated as skeletal muscle index × serum albumin level/neutrophil-to-lymphocyte ratio. The sex-specific lowest quartile defined the Low-CXI group. Univariate and multivariate Cox proportional hazards models were applied to identify independent prognostic factors for overall survival (OS) and disease-free survival (DFS).</p> Results <p>The low-CXI group was significantly associated with older age (<i>P</i> &lt; 0.001), more severe comorbidity (<i>P</i> = 0.001), and more advanced pathological stage (<i>P</i> = 0.032). Patients in the low-CXI group had poorer OS and DFS than those in the high-CXI group (both <i>P</i> &lt; 0.001). Multivariate analysis revealed that low-CXI was independently associated with poor OS (<i>P</i> = 0.002) and DFS (<i>P</i> = 0.002). In the cause-specific survival analyses, low-CXI was a predictor of deaths from non-EC-related causes. Subdivision into pathological stage (pStage) 0–I and II/III revealed that significant survival differences according to CXI were observed in both pStage 0–I (<i>P</i> = 0.045 for OS, and 0.029 for DFS) and pStage II/III (<i>P</i> &lt; 0.001 for OS, and 0.002 for DFS) patients.</p> Conclusions <p>Low-CXI was independently associated with poor OS and DFS in patients undergoing surgery for EC, in both early- and advanced-stage patients. Furthermore, CXI may also be useful for predicting non-EC-related mortality.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Prognostic Impact of Cachexia Index in Patients Undergoing Surgery for Esophageal Cancer

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月9日

查看全文
  • Tomoki Kaname,
  • Kotaro Sugawara,
  • Koichi Yagi,
  • Shoh Yajima,
  • Yoshiyuki Miwa,
  • Shuichiro Oya,
  • Asami Okamoto,
  • Raito Asaoka,
  • Haruki Kojima,
  • Yoshifumi Baba

摘要

Background

Cachexia index (CXI) is a recently proposed biomarker reflecting the cachectic condition, including inflammation, sarcopenia and nutritional status, of patients with various malignancies. We evaluated its prognostic impact in patients undergoing esophagectomy for esophageal cancer (EC).

Methods

A total of 378 patients were retrospectively reviewed. CXI was calculated as skeletal muscle index × serum albumin level/neutrophil-to-lymphocyte ratio. The sex-specific lowest quartile defined the Low-CXI group. Univariate and multivariate Cox proportional hazards models were applied to identify independent prognostic factors for overall survival (OS) and disease-free survival (DFS).

Results

The low-CXI group was significantly associated with older age (P < 0.001), more severe comorbidity (P = 0.001), and more advanced pathological stage (P = 0.032). Patients in the low-CXI group had poorer OS and DFS than those in the high-CXI group (both P < 0.001). Multivariate analysis revealed that low-CXI was independently associated with poor OS (P = 0.002) and DFS (P = 0.002). In the cause-specific survival analyses, low-CXI was a predictor of deaths from non-EC-related causes. Subdivision into pathological stage (pStage) 0–I and II/III revealed that significant survival differences according to CXI were observed in both pStage 0–I (P = 0.045 for OS, and 0.029 for DFS) and pStage II/III (P < 0.001 for OS, and 0.002 for DFS) patients.

Conclusions

Low-CXI was independently associated with poor OS and DFS in patients undergoing surgery for EC, in both early- and advanced-stage patients. Furthermore, CXI may also be useful for predicting non-EC-related mortality.